These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
683 related items for PubMed ID: 16377864
1. Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital. Capoor MR, Nair D, Deb M, Verma PK, Srivastava L, Aggarwal P. Jpn J Infect Dis; 2005 Dec; 58(6):344-8. PubMed ID: 16377864 [Abstract] [Full Text] [Related]
3. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey. Kuzucu C, Durmaz R, Otlu B, Aktas E, Gulcan H, Cizmeci Z. New Microbiol; 2008 Jul; 31(3):401-8. PubMed ID: 18843896 [Abstract] [Full Text] [Related]
4. In vitro susceptibility of oral Candida to seven antifungal agents. Kuriyama T, Williams DW, Bagg J, Coulter WA, Ready D, Lewis MA. Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594 [Abstract] [Full Text] [Related]
5. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand JP, Han XY, Rolston KV, Safdar A, Raad II, Kontoyiannis DP. Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780 [Abstract] [Full Text] [Related]
11. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period. Comert F, Kulah C, Aktas E, Eroglu O, Ozlu N. Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749 [Abstract] [Full Text] [Related]
13. In vitro fluconazole susceptibility of 1565 clinical isolates of Candida species evaluated by the disk diffusion method performed using NCCLS M44-A guidelines. Testore GP, Dori L, Buonomini AR, Schito GC, Soro O, Fortina G, Andreoni S, Carlone N, Tullio V, Andreoni M. Diagn Microbiol Infect Dis; 2004 Nov; 50(3):187-92. PubMed ID: 15541604 [Abstract] [Full Text] [Related]
14. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study. Mallié M, Bastide JM, Blancard A, Bonnin A, Bretagne S, Cambon M, Chandenier J, Chauveau V, Couprie B, Datry A, Feuilhade M, Grillot R, Guiguen C, Lavarde V, Letscher V, Linas MD, Michel A, Morin O, Paugam A, Piens MA, Raberin H, Tissot E, Toubas D, Wade A. Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312 [Abstract] [Full Text] [Related]
15. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species]. Altuncu E, Bilgen H, Cerikçioğlu N, Ilki A, Ulger N, Bakır M, Akman I, Ozek E. Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972 [Abstract] [Full Text] [Related]
16. Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals. Zaoutis TE, Foraker E, McGowan KL, Mortensen J, Campos J, Walsh TJ, Klein JD. Diagn Microbiol Infect Dis; 2005 Aug; 52(4):295-8. PubMed ID: 15922535 [Abstract] [Full Text] [Related]